Document is current
Any future updates will be listed below
-
Authors
Palandri, Francesca
Branzanti, Filippo
Morsia, Erika
Dedola, Alessandra
Benevolo, Giulia
Tiribelli, Mario
Beggiato, Eloise
Farina, Mirko
Martino, Bruno
Caocci, Giovanni
Pugliese, Novella
Tieghi, Alessia
Crugnola, Monica
Binotto, Gianni
Cavazzini, Francesco
Abruzzese, Elisabetta
Isidori, Alessandro
Scalzulli, Emilia
D’Agostino, Domenico
Caserta, Santino
Nardo, Antonella
Lemoli, Roberto Massimo
Cilloni, Daniela
Bocchia, Monica
Pane, Fabrizio
Heidel, Florian H.
Palumbo, Giuseppe A.
Breccia, Massimo
Elli, Elena M.
Bonifacio, Massimiliano
-
Funding
Funding for this research was provided by:
Alma Mater Studiorum - Università di Bologna
- License Information
-
More Information
Article History
Received: 29 November 2024
Accepted: 10 January 2025
First Online: 20 January 2025
Declarations
:
: Francesca Palandri reports consultancy and honoraria from Novartis, BMS, AOP, Sierra Oncology, Incyte, Telios, Abbvie, Constellation-Morphosys, Sobi and GSK. Giulia Benevolo reports honoraria from Novartis, Janssen, Amgen, Takeda, and BMS. Massimo Breccia reports honoraria from Novartis, BMS, Pfizer, Incyte and is the Editor-in Chief of Annals of Hematology. Massimiliano Bonifacio reports honoraria from Novartis, BMS, Pfizer, and Incyte. Monica Crugnola reports honoraria from Novartis and Amgen. Gianni Binotto reports honoraria from Novartis, Incyte, BMS-Celgene, and Pfizer. Roberto M. Lemoli reports honoraria from Jazz, Pfizer, AbbVie, BMS, Sanofi, and StemLine. Fabrizio Pane reports honoraria from Incyte, Novartis, Jazz, BMS-Celgene, Amgen, and Gilead. Giuseppe A. Palumbo reports consultancy and honoraria from Abbvie, AOP, AstraZeneca, BMS, Incyte, GSK, Morphosys, and Novartis.
